NSW Cancer Research Education State-wide Seminar Series June 2023
Sydney Cancer Partners, in collaboration with the Maridulu Budyari Gumal (SPHERE) Cancer CAG and the NSW Regional Cancer Research Network, will be hosting the 2023 NSW Cancer Research Education State-wide Seminar Series.
These online seminars will be held on the 3rd Tuesday of each month.
“The gut microbiome and neo-adjuvant immunotherapy: implications for efficacy and toxicity.”
Immune checkpoint inhibitor (ICI) immunotherapies have revolutionised the treatment of melanoma, although drug resistance or concurrent immune-related adverse events (irAEs) still impact many patients. In this session the influence of the gut microbiome on clinical outcomes will be discussed using a large clinical trial cohort of stage III melanoma patients treated with combination anti-PD-1/anti-CTLA-4 immunotherapy in the neo-adjuvant setting. This will include discussion of the neo-adjuvant platform and microbiome-immune interactions in the context of cancer and their impact on ICI treatment outcomes.
Dr Inês da Silva. Medical Oncologist and Research Scientist, Melanoma Institute Australia, The University of Sydney
Dr Erin Shanahan. a’ Beckett Research Fellow, Microbiome & Gut Health Group, The University of Sydney
Rebecca Simpson. PhD Candidate, Melanoma Institute Australia, The University of Sydney